fty720 Search Results


94
MedChemExpress hy 15382
Hy 15382, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/FTY720+(S)-Phosphate/pmc12920735-216-37-36
Average 94 stars, based on 1 article reviews
hy 15382 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Selleck Chemicals fty720 treatment
Fty720 Treatment, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/Fingolimod+(FTY720)+HCl/pm41501029-275-1-8
Average 94 stars, based on 1 article reviews
fty720 treatment - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology fty720
Fty720, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/FTY720/pm38349185-208-15-16
Average 93 stars, based on 1 article reviews
fty720 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

97
MedChemExpress fty720
Fty720, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/Fingolimod+hydrochloride/pmc12501088-100-0-4
Average 97 stars, based on 1 article reviews
fty720 - by Bioz Stars, 2026-11
97/100 stars
  Buy from Supplier

94
MedChemExpress fingolimod
Fig. 1. <t>Fingolimod</t> effectively reduces cerebral infarction volume, alleviates cerebral edema, and improves neurological function in MCAO/R rats. (A) On the first day post-MCAO/R procedure, TTC staining images were captured, wherein the infarcted regions of
Fingolimod, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/Fingolimod/pm39207074-48-0-3
Average 94 stars, based on 1 article reviews
fingolimod - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
Tocris fty720
Testing the therapeutic potency of MSC-IPr (A) Kaplan-Meier survival curve. Tumor implantation is shown by the blue arrow, whereas vaccination is represented by black arrows. Tumor growth assessment of Ctl mice (black), DC (green), MSCγ (blue), or MSC-IPr (red). The anti-OVA western blot represents (1) OVA protein, (2) EL4, (3) cultured E.G7, and (4) E.G7 isolated from tumor masses. (B and C) Flow cytometry assessment of immune-checkpoint expression by CD8 T cells isolated from tumor masses. (D) A pie chart representing CD8 T cells expressing immune checkpoints. (E) Kaplan-Meier survival curve of mice implanted with EL4 and vaccinated using lysate-pulsed MSC-IPr. MSC-IPr alone are in red, in combination with anti-41BB in dotted black line, anti-LAG3 in yellow, anti-CTLA4 in blue, or anti-PD-1 antibodies in orange. 4-1BB is represented by dotted blue line, anti-LAG3 is in gray, anti-CTL4 is in green, and anti-PD-1 is in purple. (F) Kaplan-Meier survival curve of mice implanted as in (E) and receiving no treatment (black), anti-PD-1/4-1BB (purple), <t>FTY720</t> (green), MSC-IPr + PD-1/4-1BB (orange), or MSC-IPr + PD-1/4-1BB and FTY720 (blue). (G) Representative live in vivo imaging of mice implanted with luciferase-expressing Ctl MSCs versus MSC-IPr. (H) Assessment of the signal decay for the experiment shown in (G). (I and J) Experimental design and Kaplan-Meier survival curve of allogeneic vaccination using DCs (green), DCs + αPD-1 (dotted green), MSC-IPr (red), and MSC-IPr + αPD-1 (dotted red). Ctl mice are shown in black, whereas αPD-1 is in dotted black. For (A) to (F) and (J), n = 10/group; for (G) and (H), n = 6/group, with ∗∗p < 0.01 and ∗∗∗p < 0.001. The log rank statistical test was used for the Kaplan-Meir survival curves. Error bars represent SD. See also .
Fty720, supplied by Tocris, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/FTY+720/pmc08714858-62-0-2
Average 94 stars, based on 1 article reviews
fty720 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
TargetMol fty720 treatment
Testing the therapeutic potency of MSC-IPr (A) Kaplan-Meier survival curve. Tumor implantation is shown by the blue arrow, whereas vaccination is represented by black arrows. Tumor growth assessment of Ctl mice (black), DC (green), MSCγ (blue), or MSC-IPr (red). The anti-OVA western blot represents (1) OVA protein, (2) EL4, (3) cultured E.G7, and (4) E.G7 isolated from tumor masses. (B and C) Flow cytometry assessment of immune-checkpoint expression by CD8 T cells isolated from tumor masses. (D) A pie chart representing CD8 T cells expressing immune checkpoints. (E) Kaplan-Meier survival curve of mice implanted with EL4 and vaccinated using lysate-pulsed MSC-IPr. MSC-IPr alone are in red, in combination with anti-41BB in dotted black line, anti-LAG3 in yellow, anti-CTLA4 in blue, or anti-PD-1 antibodies in orange. 4-1BB is represented by dotted blue line, anti-LAG3 is in gray, anti-CTL4 is in green, and anti-PD-1 is in purple. (F) Kaplan-Meier survival curve of mice implanted as in (E) and receiving no treatment (black), anti-PD-1/4-1BB (purple), <t>FTY720</t> (green), MSC-IPr + PD-1/4-1BB (orange), or MSC-IPr + PD-1/4-1BB and FTY720 (blue). (G) Representative live in vivo imaging of mice implanted with luciferase-expressing Ctl MSCs versus MSC-IPr. (H) Assessment of the signal decay for the experiment shown in (G). (I and J) Experimental design and Kaplan-Meier survival curve of allogeneic vaccination using DCs (green), DCs + αPD-1 (dotted green), MSC-IPr (red), and MSC-IPr + αPD-1 (dotted red). Ctl mice are shown in black, whereas αPD-1 is in dotted black. For (A) to (F) and (J), n = 10/group; for (G) and (H), n = 6/group, with ∗∗p < 0.01 and ∗∗∗p < 0.001. The log rank statistical test was used for the Kaplan-Meir survival curves. Error bars represent SD. See also .
Fty720 Treatment, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/Fingolimod/pm41904143-334-2-6
Average 93 stars, based on 1 article reviews
fty720 treatment - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
TargetMol fingolimod hydrochloride fty 720
Testing the therapeutic potency of MSC-IPr (A) Kaplan-Meier survival curve. Tumor implantation is shown by the blue arrow, whereas vaccination is represented by black arrows. Tumor growth assessment of Ctl mice (black), DC (green), MSCγ (blue), or MSC-IPr (red). The anti-OVA western blot represents (1) OVA protein, (2) EL4, (3) cultured E.G7, and (4) E.G7 isolated from tumor masses. (B and C) Flow cytometry assessment of immune-checkpoint expression by CD8 T cells isolated from tumor masses. (D) A pie chart representing CD8 T cells expressing immune checkpoints. (E) Kaplan-Meier survival curve of mice implanted with EL4 and vaccinated using lysate-pulsed MSC-IPr. MSC-IPr alone are in red, in combination with anti-41BB in dotted black line, anti-LAG3 in yellow, anti-CTLA4 in blue, or anti-PD-1 antibodies in orange. 4-1BB is represented by dotted blue line, anti-LAG3 is in gray, anti-CTL4 is in green, and anti-PD-1 is in purple. (F) Kaplan-Meier survival curve of mice implanted as in (E) and receiving no treatment (black), anti-PD-1/4-1BB (purple), <t>FTY720</t> (green), MSC-IPr + PD-1/4-1BB (orange), or MSC-IPr + PD-1/4-1BB and FTY720 (blue). (G) Representative live in vivo imaging of mice implanted with luciferase-expressing Ctl MSCs versus MSC-IPr. (H) Assessment of the signal decay for the experiment shown in (G). (I and J) Experimental design and Kaplan-Meier survival curve of allogeneic vaccination using DCs (green), DCs + αPD-1 (dotted green), MSC-IPr (red), and MSC-IPr + αPD-1 (dotted red). Ctl mice are shown in black, whereas αPD-1 is in dotted black. For (A) to (F) and (J), n = 10/group; for (G) and (H), n = 6/group, with ∗∗p < 0.01 and ∗∗∗p < 0.001. The log rank statistical test was used for the Kaplan-Meir survival curves. Error bars represent SD. See also .
Fingolimod Hydrochloride Fty 720, supplied by TargetMol, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/Fingolimod+hydrochloride/pm42962310-163-67-70
Average 93 stars, based on 1 article reviews
fingolimod hydrochloride fty 720 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

86
Toronto Research Chemicals fty720 p
Testing the therapeutic potency of MSC-IPr (A) Kaplan-Meier survival curve. Tumor implantation is shown by the blue arrow, whereas vaccination is represented by black arrows. Tumor growth assessment of Ctl mice (black), DC (green), MSCγ (blue), or MSC-IPr (red). The anti-OVA western blot represents (1) OVA protein, (2) EL4, (3) cultured E.G7, and (4) E.G7 isolated from tumor masses. (B and C) Flow cytometry assessment of immune-checkpoint expression by CD8 T cells isolated from tumor masses. (D) A pie chart representing CD8 T cells expressing immune checkpoints. (E) Kaplan-Meier survival curve of mice implanted with EL4 and vaccinated using lysate-pulsed MSC-IPr. MSC-IPr alone are in red, in combination with anti-41BB in dotted black line, anti-LAG3 in yellow, anti-CTLA4 in blue, or anti-PD-1 antibodies in orange. 4-1BB is represented by dotted blue line, anti-LAG3 is in gray, anti-CTL4 is in green, and anti-PD-1 is in purple. (F) Kaplan-Meier survival curve of mice implanted as in (E) and receiving no treatment (black), anti-PD-1/4-1BB (purple), <t>FTY720</t> (green), MSC-IPr + PD-1/4-1BB (orange), or MSC-IPr + PD-1/4-1BB and FTY720 (blue). (G) Representative live in vivo imaging of mice implanted with luciferase-expressing Ctl MSCs versus MSC-IPr. (H) Assessment of the signal decay for the experiment shown in (G). (I and J) Experimental design and Kaplan-Meier survival curve of allogeneic vaccination using DCs (green), DCs + αPD-1 (dotted green), MSC-IPr (red), and MSC-IPr + αPD-1 (dotted red). Ctl mice are shown in black, whereas αPD-1 is in dotted black. For (A) to (F) and (J), n = 10/group; for (G) and (H), n = 6/group, with ∗∗p < 0.01 and ∗∗∗p < 0.001. The log rank statistical test was used for the Kaplan-Meir survival curves. Error bars represent SD. See also .
Fty720 P, supplied by Toronto Research Chemicals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/(S)+FTY720+Phosphate/pmc03532212-39-10-14
Average 86 stars, based on 1 article reviews
fty720 p - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Santa Cruz Biotechnology fty720p
Figure 2. S1P and <t>FTY720P</t> induce lipid accumulation in HepG2 cells. Lipid accumulation in the presence of (a) Sphk1 inhibitor PF543; (b) blockers of all S1PRs. Values are means ± SEM. N = 4. Bars not sharing a common letter are considered significantly different from each other at P < 0.05; c) various concentrations of the S1P analog FTY720P. Values are means ± SEM; N = 3. *Significantly different from the control at P < 0.05.
Fty720p, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/FTY720+Phosphate/pm37953311-62-0-47
Average 86 stars, based on 1 article reviews
fty720p - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

85
Santa Cruz Biotechnology fty720 s phosphate
Figure 5. RIP1K and HSP90 are involved in neutrophil death induced by <t>FTY720.</t> (A and B) Flow cytometric quantification of Annexin V+PI+, Annexin V+PI2, and HSP27+ neutrophils after preincubation or not with necrostatin-1 (20 mM) or Z-IETD-FMK (20 mM) for 30 min and treatment or not with FTY720 (10 mM) for 3 h. Data are from 7 independent experiments. *P , 0.05; **P , 0.01; ***P , 0.001. (C and D) Neutrophil lysates analyzed by Western blotting for caspase-8 cleavage or MLKL phosphorylation after cell death induc- tion by FTY720. Where indicated, Q-VD-OPh (20 mM), necrostatin-1 (20 mM), DPI (20 mM), or NSA (5 mM) was added for 30 min before stimulation. GAPDH analysis was performed as loading control. The results of 1 representative experiment out of 4 are presented. (E) Flow cytometric quantification of HSP27+ neutrophils incubated for 30 min in the presence of geldanamycin (10 mM), DMAG (20 mM), or radicicol (10 mM) before treatment with FTY720 (10 mM) for 3 h. Data are from 7 independent experiments. *P , 0.05; **P , 0.01.
Fty720 S Phosphate, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fty720/FTY720+(S)-Phosphate/10__1189_slash_jlb__3vma1114___522rr-34-6-10
Average 85 stars, based on 1 article reviews
fty720 s phosphate - by Bioz Stars, 2026-11
85/100 stars
  Buy from Supplier

Image Search Results


Fig. 1. Fingolimod effectively reduces cerebral infarction volume, alleviates cerebral edema, and improves neurological function in MCAO/R rats. (A) On the first day post-MCAO/R procedure, TTC staining images were captured, wherein the infarcted regions of

Journal: Journal of integrative neuroscience

Article Title: Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway.

doi: 10.31083/j.jin2308142

Figure Lengend Snippet: Fig. 1. Fingolimod effectively reduces cerebral infarction volume, alleviates cerebral edema, and improves neurological function in MCAO/R rats. (A) On the first day post-MCAO/R procedure, TTC staining images were captured, wherein the infarcted regions of

Article Snippet: Fingolimod (Cat #HY-11063, MedChemExpress, Monmouth Junction, NJ, USA) was prepared in dimethylsulfoxide (DMSO, D8371, Beijing Solebao Technology Co., Ltd., Beijing, China) and diluted in a 0.9% NaCl saline solution to final concentrations (0.5, 1.0, and 2.0 mg/kg).

Techniques: Staining

Fig. 2. Fingolimod inhibits inflammation in rats after MCAO/R. (A) Enzyme-Linked Immunosorbent Assay (ELISA) was employed to measure the serum concentrations of interleukin-1 beta (IL-1β) in rats, with data expressed as the mean ± SD and analyzed utilizing

Journal: Journal of integrative neuroscience

Article Title: Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway.

doi: 10.31083/j.jin2308142

Figure Lengend Snippet: Fig. 2. Fingolimod inhibits inflammation in rats after MCAO/R. (A) Enzyme-Linked Immunosorbent Assay (ELISA) was employed to measure the serum concentrations of interleukin-1 beta (IL-1β) in rats, with data expressed as the mean ± SD and analyzed utilizing

Article Snippet: Fingolimod (Cat #HY-11063, MedChemExpress, Monmouth Junction, NJ, USA) was prepared in dimethylsulfoxide (DMSO, D8371, Beijing Solebao Technology Co., Ltd., Beijing, China) and diluted in a 0.9% NaCl saline solution to final concentrations (0.5, 1.0, and 2.0 mg/kg).

Techniques: Enzyme-linked Immunosorbent Assay

Fig. 3. Fingolimod down-regulates the expression of HMGB1 in MCAO/R rats. (A) The expression levels of HMGB1 within the hippocampal region of these rats were measured using the technique of western blot analysis, with the assessment being conducted day 1

Journal: Journal of integrative neuroscience

Article Title: Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway.

doi: 10.31083/j.jin2308142

Figure Lengend Snippet: Fig. 3. Fingolimod down-regulates the expression of HMGB1 in MCAO/R rats. (A) The expression levels of HMGB1 within the hippocampal region of these rats were measured using the technique of western blot analysis, with the assessment being conducted day 1

Article Snippet: Fingolimod (Cat #HY-11063, MedChemExpress, Monmouth Junction, NJ, USA) was prepared in dimethylsulfoxide (DMSO, D8371, Beijing Solebao Technology Co., Ltd., Beijing, China) and diluted in a 0.9% NaCl saline solution to final concentrations (0.5, 1.0, and 2.0 mg/kg).

Techniques: Expressing, Western Blot

Fig. 4. Fingolimod inhibits TLR4 expression in MCAO/R rats. (A) The expression of TLR4 in the hippocampus of rats was detected

Journal: Journal of integrative neuroscience

Article Title: Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway.

doi: 10.31083/j.jin2308142

Figure Lengend Snippet: Fig. 4. Fingolimod inhibits TLR4 expression in MCAO/R rats. (A) The expression of TLR4 in the hippocampus of rats was detected

Article Snippet: Fingolimod (Cat #HY-11063, MedChemExpress, Monmouth Junction, NJ, USA) was prepared in dimethylsulfoxide (DMSO, D8371, Beijing Solebao Technology Co., Ltd., Beijing, China) and diluted in a 0.9% NaCl saline solution to final concentrations (0.5, 1.0, and 2.0 mg/kg).

Techniques: Expressing

Fig. 5. Fingolimod treatment reduces NF-κBp65 expression in MCAO/R rats. (A) The expression of NF-κBp65 in the hippocampus of rats was detected using western blot analysis on day 1 after MCAO/R. (B) Quantification analysis of NF-κBp65 via western blot (Data

Journal: Journal of integrative neuroscience

Article Title: Fingolimod Alleviates Inflammation after Cerebral Ischemia via HMGB1/TLR4/NF-κB Signaling Pathway.

doi: 10.31083/j.jin2308142

Figure Lengend Snippet: Fig. 5. Fingolimod treatment reduces NF-κBp65 expression in MCAO/R rats. (A) The expression of NF-κBp65 in the hippocampus of rats was detected using western blot analysis on day 1 after MCAO/R. (B) Quantification analysis of NF-κBp65 via western blot (Data

Article Snippet: Fingolimod (Cat #HY-11063, MedChemExpress, Monmouth Junction, NJ, USA) was prepared in dimethylsulfoxide (DMSO, D8371, Beijing Solebao Technology Co., Ltd., Beijing, China) and diluted in a 0.9% NaCl saline solution to final concentrations (0.5, 1.0, and 2.0 mg/kg).

Techniques: Expressing, Western Blot

Testing the therapeutic potency of MSC-IPr (A) Kaplan-Meier survival curve. Tumor implantation is shown by the blue arrow, whereas vaccination is represented by black arrows. Tumor growth assessment of Ctl mice (black), DC (green), MSCγ (blue), or MSC-IPr (red). The anti-OVA western blot represents (1) OVA protein, (2) EL4, (3) cultured E.G7, and (4) E.G7 isolated from tumor masses. (B and C) Flow cytometry assessment of immune-checkpoint expression by CD8 T cells isolated from tumor masses. (D) A pie chart representing CD8 T cells expressing immune checkpoints. (E) Kaplan-Meier survival curve of mice implanted with EL4 and vaccinated using lysate-pulsed MSC-IPr. MSC-IPr alone are in red, in combination with anti-41BB in dotted black line, anti-LAG3 in yellow, anti-CTLA4 in blue, or anti-PD-1 antibodies in orange. 4-1BB is represented by dotted blue line, anti-LAG3 is in gray, anti-CTL4 is in green, and anti-PD-1 is in purple. (F) Kaplan-Meier survival curve of mice implanted as in (E) and receiving no treatment (black), anti-PD-1/4-1BB (purple), FTY720 (green), MSC-IPr + PD-1/4-1BB (orange), or MSC-IPr + PD-1/4-1BB and FTY720 (blue). (G) Representative live in vivo imaging of mice implanted with luciferase-expressing Ctl MSCs versus MSC-IPr. (H) Assessment of the signal decay for the experiment shown in (G). (I and J) Experimental design and Kaplan-Meier survival curve of allogeneic vaccination using DCs (green), DCs + αPD-1 (dotted green), MSC-IPr (red), and MSC-IPr + αPD-1 (dotted red). Ctl mice are shown in black, whereas αPD-1 is in dotted black. For (A) to (F) and (J), n = 10/group; for (G) and (H), n = 6/group, with ∗∗p < 0.01 and ∗∗∗p < 0.001. The log rank statistical test was used for the Kaplan-Meir survival curves. Error bars represent SD. See also .

Journal: Cell Reports Medicine

Article Title: Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice

doi: 10.1016/j.xcrm.2021.100455

Figure Lengend Snippet: Testing the therapeutic potency of MSC-IPr (A) Kaplan-Meier survival curve. Tumor implantation is shown by the blue arrow, whereas vaccination is represented by black arrows. Tumor growth assessment of Ctl mice (black), DC (green), MSCγ (blue), or MSC-IPr (red). The anti-OVA western blot represents (1) OVA protein, (2) EL4, (3) cultured E.G7, and (4) E.G7 isolated from tumor masses. (B and C) Flow cytometry assessment of immune-checkpoint expression by CD8 T cells isolated from tumor masses. (D) A pie chart representing CD8 T cells expressing immune checkpoints. (E) Kaplan-Meier survival curve of mice implanted with EL4 and vaccinated using lysate-pulsed MSC-IPr. MSC-IPr alone are in red, in combination with anti-41BB in dotted black line, anti-LAG3 in yellow, anti-CTLA4 in blue, or anti-PD-1 antibodies in orange. 4-1BB is represented by dotted blue line, anti-LAG3 is in gray, anti-CTL4 is in green, and anti-PD-1 is in purple. (F) Kaplan-Meier survival curve of mice implanted as in (E) and receiving no treatment (black), anti-PD-1/4-1BB (purple), FTY720 (green), MSC-IPr + PD-1/4-1BB (orange), or MSC-IPr + PD-1/4-1BB and FTY720 (blue). (G) Representative live in vivo imaging of mice implanted with luciferase-expressing Ctl MSCs versus MSC-IPr. (H) Assessment of the signal decay for the experiment shown in (G). (I and J) Experimental design and Kaplan-Meier survival curve of allogeneic vaccination using DCs (green), DCs + αPD-1 (dotted green), MSC-IPr (red), and MSC-IPr + αPD-1 (dotted red). Ctl mice are shown in black, whereas αPD-1 is in dotted black. For (A) to (F) and (J), n = 10/group; for (G) and (H), n = 6/group, with ∗∗p < 0.01 and ∗∗∗p < 0.001. The log rank statistical test was used for the Kaplan-Meir survival curves. Error bars represent SD. See also .

Article Snippet: FTY720 , Tocris , N/A.

Techniques: Tumor Implantation, Western Blot, Cell Culture, Isolation, Flow Cytometry, Expressing, In Vivo Imaging, Luciferase

Journal: Cell Reports Medicine

Article Title: Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice

doi: 10.1016/j.xcrm.2021.100455

Figure Lengend Snippet:

Article Snippet: FTY720 , Tocris , N/A.

Techniques: Recombinant, Liposomes, Control, Flow Cytometry, Live Cell Imaging, Enzyme-linked Immunosorbent Assay, Selection, Construct, Software

Figure 2. S1P and FTY720P induce lipid accumulation in HepG2 cells. Lipid accumulation in the presence of (a) Sphk1 inhibitor PF543; (b) blockers of all S1PRs. Values are means ± SEM. N = 4. Bars not sharing a common letter are considered significantly different from each other at P < 0.05; c) various concentrations of the S1P analog FTY720P. Values are means ± SEM; N = 3. *Significantly different from the control at P < 0.05.

Journal: Scientific reports

Article Title: Effect of FTY720P on lipid accumulation in HEPG2 cells.

doi: 10.1038/s41598-023-46011-4

Figure Lengend Snippet: Figure 2. S1P and FTY720P induce lipid accumulation in HepG2 cells. Lipid accumulation in the presence of (a) Sphk1 inhibitor PF543; (b) blockers of all S1PRs. Values are means ± SEM. N = 4. Bars not sharing a common letter are considered significantly different from each other at P < 0.05; c) various concentrations of the S1P analog FTY720P. Values are means ± SEM; N = 3. *Significantly different from the control at P < 0.05.

Article Snippet: FTY720P (Cat # sc-205332A), rosiglitazone (Cat # sc-202795), anti-SREBP1 (Cat# sc-365513, Lot#B1821), anti-p-mTOR (Cat# sc-293132, Lot#K2717), anti-mTOR (Cat# sc-8319, Lot#K2415), anti-GAPDH (Cat# sc-47724, Lot# H0917) mouse primary antibodies as well as anti-mouse horse radish peroxidase (HRP) conjugated secondary antibodies (Cat# sc-2005, Lot# C2011) were purchased all from Santa Cruz Biotechnology, CA, USA.

Techniques: Control

Figure 3. Effect of FTY720P on lipid accumulation in the presence of (a) S1PR1 blocker W146. (b) S1PR2 blocker JTE 013. (c) S1PR4 blocker CYM50358. Values are means ± SEM; N = 5. Bars not sharing a common letter are considered significantly different from each other at P < 0.05.

Journal: Scientific reports

Article Title: Effect of FTY720P on lipid accumulation in HEPG2 cells.

doi: 10.1038/s41598-023-46011-4

Figure Lengend Snippet: Figure 3. Effect of FTY720P on lipid accumulation in the presence of (a) S1PR1 blocker W146. (b) S1PR2 blocker JTE 013. (c) S1PR4 blocker CYM50358. Values are means ± SEM; N = 5. Bars not sharing a common letter are considered significantly different from each other at P < 0.05.

Article Snippet: FTY720P (Cat # sc-205332A), rosiglitazone (Cat # sc-202795), anti-SREBP1 (Cat# sc-365513, Lot#B1821), anti-p-mTOR (Cat# sc-293132, Lot#K2717), anti-mTOR (Cat# sc-8319, Lot#K2415), anti-GAPDH (Cat# sc-47724, Lot# H0917) mouse primary antibodies as well as anti-mouse horse radish peroxidase (HRP) conjugated secondary antibodies (Cat# sc-2005, Lot# C2011) were purchased all from Santa Cruz Biotechnology, CA, USA.

Techniques:

Figure 4. S1PR3 and Gq mediate the FTY720P effect on lipid accumulation. (a) Effect of FTY720P on lipid accumulation in the presence of S1PR3 blocker CAY10444. (b) Effect of FTY720P on lipid accumulation in the presence of the Gq inhibitor YM254890. (c) Protein expression of S1PR3. The blot is representative of an experiment repeated 3 times. Values were normalized to GAPDH and reported as arbitrary densitometry units. All values are means ± SEM; N = 3. Bars not sharing a common letter are considered significantly different from each other at P < 0.05.

Journal: Scientific reports

Article Title: Effect of FTY720P on lipid accumulation in HEPG2 cells.

doi: 10.1038/s41598-023-46011-4

Figure Lengend Snippet: Figure 4. S1PR3 and Gq mediate the FTY720P effect on lipid accumulation. (a) Effect of FTY720P on lipid accumulation in the presence of S1PR3 blocker CAY10444. (b) Effect of FTY720P on lipid accumulation in the presence of the Gq inhibitor YM254890. (c) Protein expression of S1PR3. The blot is representative of an experiment repeated 3 times. Values were normalized to GAPDH and reported as arbitrary densitometry units. All values are means ± SEM; N = 3. Bars not sharing a common letter are considered significantly different from each other at P < 0.05.

Article Snippet: FTY720P (Cat # sc-205332A), rosiglitazone (Cat # sc-202795), anti-SREBP1 (Cat# sc-365513, Lot#B1821), anti-p-mTOR (Cat# sc-293132, Lot#K2717), anti-mTOR (Cat# sc-8319, Lot#K2415), anti-GAPDH (Cat# sc-47724, Lot# H0917) mouse primary antibodies as well as anti-mouse horse radish peroxidase (HRP) conjugated secondary antibodies (Cat# sc-2005, Lot# C2011) were purchased all from Santa Cruz Biotechnology, CA, USA.

Techniques: Expressing

Figure 5. Effect of FTY720P on lipid accumulation in the presence of (a) the PI3K inhibitor wortmannin. (b) the mTOR inhibitor rapamycin. All values are means ± SEM; N = 4. Bars not sharing a common letter are considered significantly different from each other at P < 0.05.

Journal: Scientific reports

Article Title: Effect of FTY720P on lipid accumulation in HEPG2 cells.

doi: 10.1038/s41598-023-46011-4

Figure Lengend Snippet: Figure 5. Effect of FTY720P on lipid accumulation in the presence of (a) the PI3K inhibitor wortmannin. (b) the mTOR inhibitor rapamycin. All values are means ± SEM; N = 4. Bars not sharing a common letter are considered significantly different from each other at P < 0.05.

Article Snippet: FTY720P (Cat # sc-205332A), rosiglitazone (Cat # sc-202795), anti-SREBP1 (Cat# sc-365513, Lot#B1821), anti-p-mTOR (Cat# sc-293132, Lot#K2717), anti-mTOR (Cat# sc-8319, Lot#K2415), anti-GAPDH (Cat# sc-47724, Lot# H0917) mouse primary antibodies as well as anti-mouse horse radish peroxidase (HRP) conjugated secondary antibodies (Cat# sc-2005, Lot# C2011) were purchased all from Santa Cruz Biotechnology, CA, USA.

Techniques:

Figure 6. Effect of FTY720P on lipid accumulation in the presence of (a) the SREBP inhibitor fatostatin. (b) The PPARγ inhibitor GW9662. Values are means ± SEM; N = 5. Bars not sharing a common letter are considered significantly different from each other at P < 0.05.

Journal: Scientific reports

Article Title: Effect of FTY720P on lipid accumulation in HEPG2 cells.

doi: 10.1038/s41598-023-46011-4

Figure Lengend Snippet: Figure 6. Effect of FTY720P on lipid accumulation in the presence of (a) the SREBP inhibitor fatostatin. (b) The PPARγ inhibitor GW9662. Values are means ± SEM; N = 5. Bars not sharing a common letter are considered significantly different from each other at P < 0.05.

Article Snippet: FTY720P (Cat # sc-205332A), rosiglitazone (Cat # sc-202795), anti-SREBP1 (Cat# sc-365513, Lot#B1821), anti-p-mTOR (Cat# sc-293132, Lot#K2717), anti-mTOR (Cat# sc-8319, Lot#K2415), anti-GAPDH (Cat# sc-47724, Lot# H0917) mouse primary antibodies as well as anti-mouse horse radish peroxidase (HRP) conjugated secondary antibodies (Cat# sc-2005, Lot# C2011) were purchased all from Santa Cruz Biotechnology, CA, USA.

Techniques:

Figure 13. The signaling pathway activated by FTY720P.

Journal: Scientific reports

Article Title: Effect of FTY720P on lipid accumulation in HEPG2 cells.

doi: 10.1038/s41598-023-46011-4

Figure Lengend Snippet: Figure 13. The signaling pathway activated by FTY720P.

Article Snippet: FTY720P (Cat # sc-205332A), rosiglitazone (Cat # sc-202795), anti-SREBP1 (Cat# sc-365513, Lot#B1821), anti-p-mTOR (Cat# sc-293132, Lot#K2717), anti-mTOR (Cat# sc-8319, Lot#K2415), anti-GAPDH (Cat# sc-47724, Lot# H0917) mouse primary antibodies as well as anti-mouse horse radish peroxidase (HRP) conjugated secondary antibodies (Cat# sc-2005, Lot# C2011) were purchased all from Santa Cruz Biotechnology, CA, USA.

Techniques:

Figure 5. RIP1K and HSP90 are involved in neutrophil death induced by FTY720. (A and B) Flow cytometric quantification of Annexin V+PI+, Annexin V+PI2, and HSP27+ neutrophils after preincubation or not with necrostatin-1 (20 mM) or Z-IETD-FMK (20 mM) for 30 min and treatment or not with FTY720 (10 mM) for 3 h. Data are from 7 independent experiments. *P , 0.05; **P , 0.01; ***P , 0.001. (C and D) Neutrophil lysates analyzed by Western blotting for caspase-8 cleavage or MLKL phosphorylation after cell death induc- tion by FTY720. Where indicated, Q-VD-OPh (20 mM), necrostatin-1 (20 mM), DPI (20 mM), or NSA (5 mM) was added for 30 min before stimulation. GAPDH analysis was performed as loading control. The results of 1 representative experiment out of 4 are presented. (E) Flow cytometric quantification of HSP27+ neutrophils incubated for 30 min in the presence of geldanamycin (10 mM), DMAG (20 mM), or radicicol (10 mM) before treatment with FTY720 (10 mM) for 3 h. Data are from 7 independent experiments. *P , 0.05; **P , 0.01.

Journal: Journal of Leukocyte Biology

Article Title: Rapid externalization of 27-kDa heat shock protein (HSP27) and atypical cell death in neutrophils treated with the sphingolipid analog drug FTY720

doi: 10.1189/jlb.3vma1114-522rr

Figure Lengend Snippet: Figure 5. RIP1K and HSP90 are involved in neutrophil death induced by FTY720. (A and B) Flow cytometric quantification of Annexin V+PI+, Annexin V+PI2, and HSP27+ neutrophils after preincubation or not with necrostatin-1 (20 mM) or Z-IETD-FMK (20 mM) for 30 min and treatment or not with FTY720 (10 mM) for 3 h. Data are from 7 independent experiments. *P , 0.05; **P , 0.01; ***P , 0.001. (C and D) Neutrophil lysates analyzed by Western blotting for caspase-8 cleavage or MLKL phosphorylation after cell death induc- tion by FTY720. Where indicated, Q-VD-OPh (20 mM), necrostatin-1 (20 mM), DPI (20 mM), or NSA (5 mM) was added for 30 min before stimulation. GAPDH analysis was performed as loading control. The results of 1 representative experiment out of 4 are presented. (E) Flow cytometric quantification of HSP27+ neutrophils incubated for 30 min in the presence of geldanamycin (10 mM), DMAG (20 mM), or radicicol (10 mM) before treatment with FTY720 (10 mM) for 3 h. Data are from 7 independent experiments. *P , 0.05; **P , 0.01.

Article Snippet: Cells were incubated with FTY720 and FTY720 (S)-phosphate (both from Santa Cruz Biotechnology, Santa Cruz, CA, USA) or cycloheximide (Sigma, St. Louis, MO, USA) at 3 3 10/ml for 3 h. In some cases, neutrophils were preincubated for 30 min with necrostatin-1 or Z-IETD-FMK (both from Sigma); Q-VD-OPh (R&D Systems, Minneapolis, MN, USA); NSA (Tocris, Bristol, United Kingdom); geldanamycin, 17-DMAG, and radicicol (all from InvivoGen, San Diego, CA, USA); OA (Santa Cruz Biotechnology); or DPI (Sigma).

Techniques: Western Blot, Phospho-proteomics, Control, Incubation